We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$20.6B
AUM Growth
+$1.37B
Cap. Flow
-$108M
Cap. Flow %
-0.52%
Top 10 Hldgs %
24.22%
Holding
1,585
New
42
Increased
433
Reduced
362
Closed
69

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$140M
2
JNJ icon
Johnson & Johnson
JNJ
+$83.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$76.7M
4
JPM icon
JPMorgan Chase
JPM
+$56.2M
5
AVGO icon
Broadcom
AVGO
+$55.8M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$103M
2
BMY icon
Bristol-Myers Squibb
BMY
+$77.8M
3
CTXS
Citrix Systems Inc
CTXS
+$75.4M
4
MET icon
MetLife
MET
+$74.6M
5
ZTS icon
Zoetis
ZTS
+$56.4M

Sector Composition

Rank Sector Weight
1 Technology 27.13%
2 Healthcare 21.68%
3 Financials 14.1%
4 Consumer Discretionary 8.35%
5 Consumer Staples 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$1.17B 5.69%
4,892,655
+213,273
+5% +$51.2M
AAPL icon
2
Apple
AAPL
$4.89T
$1.16B 5.65%
8,957,785
+979,069
+12% +$140M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.9T
$485M 2.35%
5,461,238
+803,531
+17% +$76.7M
UNH icon
4
UnitedHealth
UNH
$382B
$379M 1.84%
714,244
-84,344
-11% -$44.7M
V icon
5
Visa
V
$677B
$318M 1.54%
1,530,315
+266,784
+21% +$53.8M
TMO icon
6
Thermo Fisher Scientific
TMO
$211B
$315M 1.53%
571,156
-89,326
-14% -$47.3M
PEP icon
7
PepsiCo
PEP
$186B
$313M 1.52%
1,732,771
-153,927
-8% -$27.5M
JNJ icon
8
Johnson & Johnson
JNJ
$635B
$293M 1.42%
1,659,451
+485,948
+41% +$83.9M
AMZN icon
9
Amazon
AMZN
$2.5T
$287M 1.39%
3,421,429
-543,681
-14% -$53.7M
MRK icon
10
Merck
MRK
$324B
$265M 1.29%
2,392,134
+439,625
+23% +$44.9M
LLY icon
11
Eli Lilly
LLY
$1.07T
$255M 1.24%
697,667
-99,932
-13% -$35.4M
DHR icon
12
Danaher
DHR
$135B
$247M 1.2%
1,049,599
-93,211
-8% -$21.6M
KO icon
13
Coca-Cola
KO
$354B
$231M 1.12%
3,633,578
+44,981
+1% +$2.72M
JPM icon
14
JPMorgan Chase
JPM
$939B
$226M 1.09%
1,682,053
+443,754
+36% +$56.2M
ABBV icon
15
AbbVie
ABBV
$458B
$225M 1.09%
1,393,195
-39,488
-3% -$6.05M
MA icon
16
Mastercard
MA
$477B
$215M 1.04%
618,961
+106,570
+21% +$35.1M
NVDA icon
17
NVIDIA
NVDA
$5.01T
$207M 1.01%
14,189,080
+767,980
+6% +$11.3M
PFE icon
18
Pfizer
PFE
$140B
$200M 0.97%
3,906,544
-214,422
-5% -$10.3M
MDLZ icon
19
Mondelez International
MDLZ
$77.7B
$182M 0.88%
2,726,799
-733,205
-21% -$46.4M
PG icon
20
Procter & Gamble
PG
$343B
$179M 0.87%
1,180,741
-50,987
-4% -$7.15M
BAC icon
21
Bank of America
BAC
$435B
$179M 0.87%
5,400,223
+462,109
+9% +$15.9M
DIS icon
22
Walt Disney
DIS
$165B
$172M 0.83%
1,975,201
+145,582
+8% +$13.9M
ABT icon
23
Abbott
ABT
$180B
$162M 0.78%
1,472,065
-13,777
-0.9% -$1.43M
LIN icon
24
Linde
LIN
$237B
$155M 0.75%
474,093
+58,921
+14% +$18.5M
HD icon
25
Home Depot
HD
$332B
$154M 0.75%
488,822
+68,660
+16% +$20.9M

Similar funds

KBC Group's Q4 2022 Portfolio in Review

As of Q4 2022, KBC Group held 1,585 positions worth $20.6B, up 7.1% from $19.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

KBC Group's Q4 2022 filing shows 42 new, 433 increased, 362 reduced and 69 closed positions. Its largest new stake was Ferguson: 50,222 shares worth $6.38M. The largest sale was Nike, an estimated $103M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q4 2022 buy was Ferguson: 50,222 shares worth $6.38M.
  • KBC Group added most to Apple in Q4 2022, an estimated $140M increase.
  • KBC Group's biggest Q4 2022 reduction was Nike, cutting an estimated $103M.
  • KBC Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $75.4M.
  • KBC Group's ten largest holdings make up 24% of its $20.6B portfolio in Q4 2022.
  • KBC Group opened 42 new positions and closed 69 in Q4 2022.
  • KBC Group's portfolio value rose 7.1% quarter-over-quarter to $20.6B.

Based on KBC Group's 13F filing for Q4 2022, filed 13 Feb 2023.